{
  "id": 3467881,
  "title": "STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake",
  "url": "https://urgent.news/2026/08/26/stat-new-treatments-for-common-cardiovascular-risk-factor-near-the",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T08:30:00.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/08/26/lp-a-drugs-novartis-amgen-lilly-potential-heart-disease-blockbuster/"
  },
  "original_language": "en",
  "account": null,
  "summary": "High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot. Drugmakers are hoping to change that.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}